ribavirin

Generic: ribavirin

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ribavirin
Generic Name ribavirin
Labeler aurobindo pharma limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ribavirin 200 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-290
Product ID 65862-290_229cfa05-05e1-493e-87ba-0511fed12e66
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079117
Listing Expiration 2026-12-31
Marketing Start 2009-09-17

Pharmacologic Class

Established (EPC)
nucleoside analog antiviral [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862290
Hyphenated Format 65862-290

Supplemental Identifiers

RxCUI
312817
UNII
49717AWG6K
NUI
N0000175459 N0000175466

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ribavirin (source: ndc)
Generic Name ribavirin (source: ndc)
Application Number ANDA079117 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (65862-290-05)
  • 180 CAPSULE in 1 BOTTLE (65862-290-18)
  • 42 CAPSULE in 1 BOTTLE (65862-290-42)
  • 56 CAPSULE in 1 BOTTLE (65862-290-56)
  • 70 CAPSULE in 1 BOTTLE (65862-290-70)
  • 84 CAPSULE in 1 BOTTLE (65862-290-84)
source: ndc

Packages (6)

65862-290-05 500 CAPSULE in 1 BOTTLE (65862-290-05) 65862-290-18 180 CAPSULE in 1 BOTTLE (65862-290-18) 65862-290-42 42 CAPSULE in 1 BOTTLE (65862-290-42) 65862-290-56 56 CAPSULE in 1 BOTTLE (65862-290-56) 65862-290-70 70 CAPSULE in 1 BOTTLE (65862-290-70) 65862-290-84 84 CAPSULE in 1 BOTTLE (65862-290-84)

Ingredients (1)

ribavirin (200 mg/1)

Linked Drug Pages (1)

Ribavirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "229cfa05-05e1-493e-87ba-0511fed12e66", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["312817"], "spl_set_id": ["35f99f76-f2ef-4a81-91ff-285419664be3"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-290-05)", "package_ndc": "65862-290-05", "marketing_start_date": "20090917"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (65862-290-18)", "package_ndc": "65862-290-18", "marketing_start_date": "20090917"}, {"sample": false, "description": "42 CAPSULE in 1 BOTTLE (65862-290-42)", "package_ndc": "65862-290-42", "marketing_start_date": "20090917"}, {"sample": false, "description": "56 CAPSULE in 1 BOTTLE (65862-290-56)", "package_ndc": "65862-290-56", "marketing_start_date": "20090917"}, {"sample": false, "description": "70 CAPSULE in 1 BOTTLE (65862-290-70)", "package_ndc": "65862-290-70", "marketing_start_date": "20090917"}, {"sample": false, "description": "84 CAPSULE in 1 BOTTLE (65862-290-84)", "package_ndc": "65862-290-84", "marketing_start_date": "20090917"}], "brand_name": "Ribavirin", "product_id": "65862-290_229cfa05-05e1-493e-87ba-0511fed12e66", "dosage_form": "CAPSULE", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "65862-290", "generic_name": "Ribavirin", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ribavirin", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "200 mg/1"}], "application_number": "ANDA079117", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}